AIM
ROIV icon

Aigen Investment Management’s Roivant Sciences ROIV Stock Holding History

Aigen Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,030
Closed -$273K – 916
2025
Q3 		$273K Buy
+18,030
New +$223K 0.04% 568
2023
Q3 		– Sell
-13,546
Closed -$137K – 1046
2023
Q2 		$137K Buy
+13,546
New +$121K 0.02% 658

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Aigen Investment Management's ROIV Position: Q4 2025 in Review

Aigen Investment Management sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 18,030 shares — an estimated $273K sold.

Aigen Investment Management first reported a position in ROIV in Q2 2023 and held it in 2 quarters. The position peaked at $273K in Q3 2025. 399 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Aigen Investment Management reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 18,030 Roivant Sciences shares in Q4 2025, an estimated $273K.
  • Aigen Investment Management first reported a position in Roivant Sciences in Q2 2023 and held it in 2 quarters.
  • Aigen Investment Management's Roivant Sciences position peaked at $273K in Q3 2025.
  • 399 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.